Clinical Trials Directory

Trials / Completed

CompletedNCT05946408

Effects of Antenatal Exercises in Primagravida

Effects Of Supervised Antenatal Exercises On Low Back Pain And Depression In Primigravida

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The goal of this Randomized control trial is to determine the effects of antenatal exercises on low back pain in Primagravida. The main questions it aims to answer are whether supervised antenatal exercises have an effect on low back pain and depression in primagravida.

Detailed description

Females usually tend to avoid physical activity during pregnancy. Concept of antenatal exercises and its effects on low back pain or antenatal depression is yet not common amongst pregnant females in Pakistan. Low back pain and antenatal depression are common in pregnancy. These can have an impact on both their own health and the health of their unborn child. Understanding the benefits of antenatal exercises will encourage pregnant females to engage in regular physical activity. The results of this study will help physical therapists to implement effective exercise interventions for this population.

Conditions

Interventions

TypeNameDescription
OTHERSupervised antenatal exercisesSupervised antenatal exercises along with education twice a week. Protocol consists of warm up (10 min), Aerobic training (20 mins, 60-75% of max. HR), Strength training (25 minutes), followed by a cool down of 15 minutes. The Interventions to be provided for a period of 12 weeks.
OTHERAntenatal EducationAntenatal education at 12th week of pregnancy. Which consists of education on Posture in pregnancy, Role of pelvic floor muscles, Labor and breathing and relaxation techniques.

Timeline

Start date
2023-07-05
Primary completion
2023-12-01
Completion
2023-12-21
First posted
2023-07-14
Last updated
2023-12-29

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05946408. Inclusion in this directory is not an endorsement.